Albert P Parker Zynerba Pharmaceuticals, Inc. (ZYNE) insider trading activity

Albert P Parker is Chief Legal Officer of Zynerba Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of ZYNE, which is worth approximately $0. The most recent transaction as insider was on Oct 10, 2023, when has been sold 312,018 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Albert P Parker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	312,018 Reduced 100.0%	0 Common Stock
Oct 10 2023	BUY Grant, award, or other acquisition	-	85,000 Added 23.39%	278,333 Common Stock
Feb 15 2023	SELL Open market or private sale	$1,713 $0.54 p/Share	3,173 Reduced 1.38%	227,018 Common Stock
Feb 08 2023	SELL Payment of exercise price or tax liability	$3,277 $0.6 p/Share	5,463 Reduced 2.32%	230,191 Common Stock
Feb 07 2023	BUY Grant, award, or other acquisition	-	18,864 Added 7.41%	235,654 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$3,504 $0.6 p/Share	5,841 Reduced 2.62%	216,790 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	17,631 Added 7.34%	222,631 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	170,000 Added 45.33%	205,000 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	35,000 Added 50.0%	35,000 Common Stock

Also insider at

OCX

Oncocyte Corp Healthcare

COO

APP

Albert P Parker

Chief Legal Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYNE shares.

Notify only if

Value

Insider Trading

Get notified when an Zynerba Pharmaceuticals, Inc. insider buys or sells ZYNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zynerba Pharmaceuticals, Inc.

Track Activities on ZYNE

Account